Abstract
Abstract
Background
Acquired hemophilia A (AHA) is a rare acquired bleeding disorder occurred due to the formation of inhibitory antibodies neutralizing endogenous factor VIII.
Main body
About half the cases are idiopathic. Symptoms include severe and unexpected bleeding that could be life-threatening. High index of suspicion should be raised when unexplained subcutaneous or post-surgical bleeding with isolated prolonged APTT.
Conclusions
Acquired hemophilia A is a rare underdiagnosed underreported acquired hemostatic disorder that presents with sudden usually life-threatening bleeding; it is crucial to raise awareness and suspicion index of clinicians for early diagnosis and treatment to avoid morbidity and mortality.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Singh N, Singh Lubana S, Dabrowski L (2020) Acquired hemophilia A: a potentially fatal bleeding disorder. Cureus. 12(6):e8744
2. Huth-Kühne A, Baudo F, Collins P et al (2009) International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 94:566–575
3. Franchini M, Lippi G (2011) Acquired hemophilia A. Adv Clin Chem 54:71–80
4. Bouvry P, Recloux P (1994) Acquired hemophilia. Haematologica 79:550–556
5. Kessler CM, Ma AD, Al-Mondhiry HA, Gut RZ, Cooper DL (2016) Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry. Blood Coagul Fibrinolysis 27(7):761-769
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献